Patient Registry Software Market Set for Rapid Growth and Trend by 2022

The growth of the market is attributed to the growing implementation of government initiatives to build patient registries, rising pressure to improve the quality of care and reduce healthcare costs, rising adoption of EHRs, and growing use of patient registry data for post-marketing surveillance. The rising number of accountable care organizations, emergence of cloud-based patient registry solutions & high adoption rate of subscription models, and shifting focus towards patient-powered research networks (PPRNS) are expected to offer significant growth opportunities for players in the coming years.

The global Patient Registry Software Market is expected to reach USD 1,429.1 Million by 2022 from USD 807.4 Million in 2017, at a CAGR of 12.1%.

Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144694594

Based on type of registry, the market is segmented into product registries (medical device and drug registries), health service registries, and disease registries (diabetes registries, cardiovascular registries, cancer registries, rare disease registries, asthma registries, chronic kidney disease registries, orthopedic registries, and other registries). The disease registries segment is expected to dominate the market in 2017. The growth of this segment can be attributed to the factors such as increasing aging population, rising prevalence of chronic and rare & new diseases, growing awareness on the role of registries in health management, and increasing adoption of EHRs across the globe.

Based on end user, the market is segmented into government organizations & TPAs (third-party administrators); hospitals and medical practices; private payers; pharmaceutical, biotechnology, and medical device companies; and research centers. The hospitals and medical practices segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to factors like increasing focus on improving the quality of patient care, growing adoption of EHRs, and implementation of pay-for-performance initiatives.

In 2017, North America is expected to account for the largest share of the market. Growth in the North American market can largely be attributed to the presence of major patient registry software developing players and the high adoption rate of these solutions in the region. Other drivers include the increasing need to integrate healthcare systems, government funding for developing patient registries, rising focus on population health management & health information exchange, increasing adoption of HCIT as a cost-containment measure, and increasing participation of non-profit and private organizations in improving patient care quality.

Read more :- https://www.marketsandmarkets.com/PressReleases/patient-registry-software.asp

The patient registry software market is fragmented with several big and small players. Players offer several products across different subsegments of this market. Key players in this market include Phytel, Inc. (US), QUINTILES IMS HOLDINGS, INC. (US), Liaison Technologies. (US), ImageTrend, Inc. (US), FIGmd, Inc. (US), McKesson Corporation (US), CECity.com Inc. (a Premier, Inc. Company) (US), Dacima Software Inc. (US), Global Vision Technologies, Inc. (US), ifa systems AG, (Germany), INC RESEARCH HOLDINGS, INC. (US), M2S (A Medstreaming Company) (US), Optum, Inc (A part of UnitedHealth Group Incorporated) (US), EVADO Pty. Ltd. (Australia), and Velos, Inc. (US).

Covid 19 Impact on the Respiratory Diagnostics Market

The report provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.          

The global Respiratory Diagnostics Market is projected to reach USD 7.45 Billion by 2021 from USD 5.24 Billion in 2016, at a CAGR of 7.3% from 2016 to 2021.

Major factors driving the market growth are increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in respiratory diagnostic systems. On the other hand, rising healthcare costs and reimbursement concerns are the major factors restraining the growth of the respiratory diagnostics market. High potential emerging markets such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore offer significant growth opportunities for the key players in the respiratory diagnostics market.

Download PDF Brochure :- 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163390459

The global respiratory diagnostics market is segmented on the basis of product and service, test type, disease, end user, and region. On the basis of product and service, the respiratory diagnostics market is segmented into instruments and devices, assays and reagents, and software and services. The instruments and devices segment is expected to account for the largest share of the respiratory diagnostics market in 2016. The continuous requirement of diagnostic instruments and devices in laboratories, point-of-care, and home care is a major factor driving the uptake of instruments and devices.

On the basis of test type, the respiratory diagnostics market is broadly classified into mechanical tests, imaging tests, traditional diagnostic tests, and molecular diagnostic tests. In 2016, the traditional diagnostic tests segment is expected to account for the largest share of the respiratory diagnostics market. The large share of this segment is primarily attributed to the quick turnaround time of these tests.

On the basis of disease, the respiratory diagnostics market is segmented into asthma, chronic obstructive pulmonary disease, lung cancer, tuberculosis, and other diseases. The tuberculosis segment is expected to account for the largest share of the respiratory diagnostics market in 2016. The large share of this segment is primarily attributed to the increase in tobacco smoking and growing air pollution levels.

On the basis of end user, the respiratory diagnostics market is categorized into hospital/clinical laboratories, reference laboratories, physician offices, and other end users (including blood banks, point-of-care testing, patient self-testing, home health agencies, nursing homes, and local public health laboratories). 

North America is expected to account for the largest share of the global respiratory diagnostics market in 2016, followed by Europe. The growth of the respiratory diagnostics market in North America is majorly driven by the rising prevalence of respiratory diseases and growing geriatric population in the region. 

Read more :-

https://www.marketsandmarkets.com/PressReleases/respiratory-diagnostics.asp

The respiratory diagnostics market is dominated by established players such as Philips Healthcare (Netherlands), Becton, Dickinson and Company (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Alere, Inc. (U.S.).

Technological Advancements in Medical Imaging Systems and Analysis Software

The report "Medical Image Analysis Software Market is expected to reach USD 3.88 billion by 2022 from USD 2.61 billion in 2017, at a CAGR of 8.2% during the forecast period.  Market growth is driven by technological advancements in medical imaging systems and analysis software, growing public- and private-sector investments in the medical imaging market, increasing use of imaging equipment due to rising prevalence of chronic diseases, fusion of imaging technologies and growing applications of computer-aided diagnosis.

However, budgetary constraints are restraining the growth of this medical image analysis software market to a certain extent. The base year considered for the study is 2017, and the forecast has been provided for the period between 2018 and 2023.

Major Market Developments

• In December 2016, Pickering Electronics Philips Healthcare (US) introduced Signed a 10-year partnership with Expert Group of Companies (Russia) to jointly improve the efficiency of the delivery of patient care in Russia. 
• In June 2015, Siemens Healthcare (Germany) signed a contract with William Osler Health System (Canada) to expand its presence in the Canadian market.
• In November 2015, Vital Images, Inc. (US) partnered with Heilind Electronics (US), a global distributor to expand the company’s sensor product line through Stratasys, Ltd. (US) to develop print-on-demand services using Vital’s industry-leading Vitrea advanced visualization software and Stratasys’ 3D printing services.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=846

Market Drivers:-

• Technological advancements in medical imaging systems and analysis software
• Growing public- and private-sector investments in the medical imaging market
• Increasing use of imaging equipment due to rising prevalence of chronic diseases
• Fusion of imaging technologies
• Growing applications of computer-aided diagnosis

Regional Analysis:-
Of the various regions, North America is projected to account for the largest share of the global medical image analysis software market by 2022. A recently published report of the World Health Organization (WHO) stated that by 2020, chronic diseases would account for nearly 73% of all deaths and 60% of the global burden of disease. Moreover, the number of imaging centers is increasing in the region in tandem with the growing geriatric population and the increasing prevalence of various diseases.

Read more: - https://www.marketsandmarkets.com/PressReleases/medical-image-analysis.asp

Top Key Players:-
The increasing presence of new and established players in the medical image analysis software market is likely to intensify the competition. A few prominent market players operating in this market include AQUILAB (France), AGFA Healthcare (Belgium), Esaote S.p.A (Italy), Carestream Health, Inc. (US), and GE Healthcare (US).

Particle Size Analysis Market: Drivers, Restraints, Opportunities and Challenges

The major factors driving the growth of the Particle Size Analysis Market include increasing research activities in the field of nanotechnology; technological advancements in particle size analyzers; increasing investment in pharmaceutical R&D; and stringent regulatory guidelines for product quality across industries.

The global particle size analysis market is expected to reach USD 405.0 Million by 2022 from USD 314.3 Million in 2017, at a CAGR of 5.2%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833 

Market Drivers: -
            1.Increasing Research Activities in the Field of Nanotechnology
            2.Technological Advancements in Particle Size Analyzers
            3.Increasing Investments in Pharmaceutical R&D
            4.Development of Technologically Advanced Instruments Requiring Low Sample Volumes and Preparation Time
            5.Stringent Regulatory Guidelines for Product Quality Across Industries
            6.Funding Activities Increasing the Purchasing Power of Research Institutions
is attributed to laser diffraction’s wide dynamic measurement range, a feature that significantly increases its application areas.

Industry Analysis:-
Based on the type of industry, the global particle size analysis market is classified into five major segments—healthcare; chemicals and petroleum; mining, minerals, and cement; food and beverage; and other industries. The last segment comprises industries related to inks, toners, paint, coatings, cosmetics, and environmental analysis. The healthcare industry segment is expected to account for the largest share of the particle size analysis market in 2017 due to its dominance can be attributed to the increasing applications of nanotechnology in medical science, the rapid growth of pharmaceuticals in the healthcare industry.

Read More :- ( Particle size analysis market) : https://www.marketsandmarkets.com/PressReleases/particle-size-analysis.asp  

Geographical Analysis:
Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global particle size analysis market during the forecast period (2017-2022). The large share of this region can be attributed to the increasing government support for nanotechnology research and strict regulatory guidelines on product quality. In addition, increasing efforts by market players to expand their business in the US is one of the key factors propelling the growth of particle size analysis in North America.

Key Players:-

The major players operating in the particle size analysis market include Malvern Instruements Limited (UK), HORIBA, Ltd. (Japan), and Beckman Coulter, Inc. (US).

Metal Implants and Medical Alloys Market worth $17.6 Billion by 2024

The global metal implants and medical alloys market is projected to reach USD 17.6 billion by 2024 from USD 11.2 billion in 2019, at a CAGR of 9.4%. Market growth is largely driven by the rapidly growing global geriatric population.

The elderly are more susceptible to various diseases and disorders such as orthopedic, dental, neurological, and cardiovascular disorders, owing to which, growth in the geriatric population will result in an increase in the demand for implants. The growing number of accidents and sports-related injuries and the increasing launch of technologically advanced products are also major factors supporting market growth.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256117768   

By type, the titanium segment is expected to account for the largest share of the metal implants and medical alloys market in 2019
On the basis of type, the titanium segment is expected to account for the largest share of the metal implants and medical alloys market in 2019. The large share of this segment can be attributed to the advantages offered by titanium, such as high biocompatibility, strength, rigidity, greater strain-bearing capacity, and greater corrosion-resistance properties as compared to other materials. Moreover, it is non-allergic, non-magnetic, and non-radio-opaque, and adheres easily to the bone without any additional coating.

By application, the orthopedic applications segment is expected to grow at the highest CAGR during the forecast period (2019–2024)
Based on application, the metal implants and medical alloys market is segmented into orthopedic, cardiovascular, dental, craniomaxillofacial, and neurological applications. The orthopedic applications segment is expected to grow at the highest CAGR in the metal implants and medical alloys market during the forecast period owing to the growing incidence of orthopedic disorders such as osteoporosis and arthritis, which result in a large patient pool for orthopedic implant procedures.

North America to dominate the metal implants and medical alloys market in 2019
North America is expected to account for the largest share of the metal implants and medical alloys market in 2019, followed by Europe and the Asia Pacific. The large share of North America in the global market can be attributed to the growing aging population and subsequent increase in the prevalence of chronic disorders in North American countries, thereby increasing demand for improved products and treatment services. Other factors supporting market growth include the growing healthcare expenditure, high accessibility to advanced technologies in countries such as the US and Canada, increasing focus on the development of innovative and technologically advanced products, and the significant presence of major product developers in the region.

Read More: - https://www.marketsandmarkets.com/PressReleases/metal-implant-medical-alloy.asp

The prominent players in the metal implants and medical alloys market are Carpenter Technology Corporation (US), Royal DSM (Netherlands), Johnson Matthey Plc (UK), ATI Specialty Alloys & Components (US), Ametek Specialty Products (US), Aperam S.A. (Luxembourg), QuesTek Innovations LLC (US), and Fort Wayne Metals (US).